Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Idiopathic Myocardial Fibrosis in Captive Chimpanzees (Pan troglodytes).

Strong V, Moittié S, Sheppard MN, Liptovszky M, White K, Redrobe S, Cobb M, Baiker K.

Vet Pathol. 2019 Oct 22:300985819879442. doi: 10.1177/0300985819879442. [Epub ahead of print]

PMID:
31640487
2.

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.

PMID:
31319389
3.

Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.

Lin JX, Yoon C, Desiderio J, Yi BC, Li P, Zheng CH, Parisi A, Huang CM, Strong VE, Yoon SS.

Br J Surg. 2019 Aug;106(9):1187-1196. doi: 10.1002/bjs.11181. Epub 2019 Jun 13.

PMID:
31197829
4.

Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre and Post-imatinib Eras.

Cavnar MJ, Seier K, Curtin C, Balachandran VP, Coit DG, Yoon SS, Crago AM, Strong VE, Tap WD, Gönen M, Antonescu CR, Brennan MF, Singer S, DeMatteo RP.

Ann Surg. 2019 Apr 2. doi: 10.1097/SLA.0000000000003277. [Epub ahead of print]

PMID:
30946076
5.

KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer.

Bang YJ, Van Cutsem E, Fuchs CS, Ohtsu A, Tabernero J, Ilson DH, Hyung WJ, Strong VE, Goetze TO, Yoshikawa T, Tang LH, Hwang PMT, Webb N, Adelberg D, Shitara K.

Future Oncol. 2019 Mar;15(9):943-952. doi: 10.2217/fon-2018-0581. Epub 2019 Feb 19.

6.

Toward More Accurate Understanding of Lymph Node Metastasis Risk in Early Gastric Cancer.

Datta J, Strong VE.

JAMA Surg. 2019 Mar 1;154(3):e185250. doi: 10.1001/jamasurg.2018.5250. Epub 2019 Mar 20. No abstract available.

PMID:
30698606
7.

Locus Coeruleus Optogenetic Light Activation Induces Long-Term Potentiation of Perforant Path Population Spike Amplitude in Rat Dentate Gyrus.

Quinlan MAL, Strong VM, Skinner DM, Martin GM, Harley CW, Walling SG.

Front Syst Neurosci. 2019 Jan 9;12:67. doi: 10.3389/fnsys.2018.00067. eCollection 2018.

8.

Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?

Mondaca S, Yoon SS, Strong VE, Ku GY, Ilson DH, Greally M, Janjigian YY.

Ann Surg. 2019 Aug;270(2):e39-e40. doi: 10.1097/SLA.0000000000003100. No abstract available.

PMID:
30480560
9.

Locus Coeruleus Phasic, But Not Tonic, Activation Initiates Global Remapping in a Familiar Environment.

Grella SL, Neil JM, Edison HT, Strong VD, Odintsova IV, Walling SG, Martin GM, Marrone DF, Harley CW.

J Neurosci. 2019 Jan 16;39(3):445-455. doi: 10.1523/JNEUROSCI.1956-18.2018. Epub 2018 Nov 26.

10.

Robotic gastrointestinal surgery.

Felder SI, Ramanathan R, Russo AE, Jimenez-Rodriguez RM, Hogg ME, Zureikat AH, Strong VE, Zeh HJ, Weiser MR.

Curr Probl Surg. 2018 Jun;55(6):198-246. doi: 10.1067/j.cpsurg.2018.07.001. Epub 2018 Aug 8. Review. No abstract available.

11.

Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):395. doi: 10.1007/s00268-018-4845-x.

PMID:
30406321
12.

Gastric Cancer Etiology and Management in Asia and the West.

Russo AE, Strong VE.

Annu Rev Med. 2019 Jan 27;70:353-367. doi: 10.1146/annurev-med-081117-043436. Epub 2018 Oct 24.

PMID:
30355265
13.

Comparison of gastric cancer survival after R0 resection in the US and China.

Li P, Huang CM, Zheng CH, Russo A, Kasbekar P, Brennan MF, Coit DG, Strong VE.

J Surg Oncol. 2018 Nov;118(6):975-982. doi: 10.1002/jso.25220. Epub 2018 Oct 17.

14.

A clinical study to evaluate the cardiopulmonary characteristics of two different anaesthetic protocols for immobilization of healthy chimpanzees (Pan troglodytes).

Strong V, Möller T, Tillman AS, Träff S, Guevara L, Martin M, Redrobe S, White K.

Vet Anaesth Analg. 2018 Nov;45(6):794-801. doi: 10.1016/j.vaa.2018.06.015. Epub 2018 Aug 23.

PMID:
30314798
15.

Autonomous detection, grading, and reporting of postoperative complications using natural language processing.

Selby LV, Narain WR, Russo A, Strong VE, Stetson P.

Surgery. 2018 Dec;164(6):1300-1305. doi: 10.1016/j.surg.2018.05.008. Epub 2018 Jul 26.

PMID:
30056994
16.

Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):385-394. doi: 10.1007/s00268-018-4726-3. Erratum in: World J Surg. 2018 Nov 7;:.

PMID:
29955938
17.

Checkpoint blockade in esophagogastric cancer.

Cohen NA, Strong VE, Janjigian YY.

J Surg Oncol. 2018 Jul;118(1):77-85. doi: 10.1002/jso.25116. Epub 2018 Jun 7. Review.

PMID:
29878357
18.

Progress in gastric cancer.

Strong VE.

Updates Surg. 2018 Jun;70(2):157-159. doi: 10.1007/s13304-018-0543-3. Epub 2018 Jun 5. Review. No abstract available.

PMID:
29869781
19.

Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.

van Beek EJAH, Hernandez JM, Goldman DA, Davis JL, McLaughlin K, Ripley RT, Kim TS, Tang LH, Hechtman JF, Zheng J, Capanu M, Schultz N, Hyman DM, Ladanyi M, Berger MF, Solit DB, Janjigian YY, Strong VE.

Ann Surg Oncol. 2018 Jul;25(7):2027-2033. doi: 10.1245/s10434-018-6502-x. Epub 2018 May 3.

20.

Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease.

Russo AE, Untch BR, Kris MG, Chou JF, Capanu M, Coit DG, Chaft JE, D'Angelica MI, Brennan MF, Strong VE.

Ann Surg. 2019 Aug;270(2):373-377. doi: 10.1097/SLA.0000000000002749.

PMID:
29578911
21.

Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort Study.

Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, Cluff K, Davis KA, Dellinger EP, Dowdy SC, Duncan K, Fedderson J, Glasgow R, Hall B, Hirsch M, Hutter M, Kimbro L, Kuvshinoff B, Makary M, Morris M, Nehring S, Ramamoorthy S, Scott R, Sovel M, Strong V, Webster A, Wick E, Aguilar JG, Carlson R, Sepkowitz K.

Infect Control Hosp Epidemiol. 2018 May;39(5):555-562. doi: 10.1017/ice.2018.40. Epub 2018 Mar 19.

22.

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.

Janjigian YY, Sanchez-Vega F, Jonsson P, Chatila WK, Hechtman JF, Ku GY, Riches JC, Tuvy Y, Kundra R, Bouvier N, Vakiani E, Gao J, Heins ZJ, Gross BE, Kelsen DP, Zhang L, Strong VE, Schattner M, Gerdes H, Coit DG, Bains M, Stadler ZK, Rusch VW, Jones DR, Molena D, Shia J, Robson ME, Capanu M, Middha S, Zehir A, Hyman DM, Scaltriti M, Ladanyi M, Rosen N, Ilson DH, Berger MF, Tang L, Taylor BS, Solit DB, Schultz N.

Cancer Discov. 2018 Jan;8(1):49-58. doi: 10.1158/2159-8290.CD-17-0787. Epub 2017 Nov 9.

23.

Comparison of Young Patients with Gastric Cancer in the United States and China.

Strong VE, Russo A, Yoon SS, Brennan MF, Coit DG, Zheng CH, Li P, Huang CM.

Ann Surg Oncol. 2017 Dec;24(13):3964-3971. doi: 10.1245/s10434-017-6073-2. Epub 2017 Oct 19.

PMID:
29052085
24.

A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy.

Shah M, Strong VE, Boughey JC.

Bull Am Coll Surg. 2017 Feb;102(2):46-8. No abstract available.

PMID:
28925240
25.

Gastrectomy for cancer: What are the benefits of a minimally invasive approach?

Strand MS, Strong VE, Fields RC, Boughey JC.

Bull Am Coll Surg. 2017 Jul;102(7):68-70. No abstract available.

PMID:
28885793
26.

Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer: Association with Pathology and Outcome.

Merkow RP, Herrera G, Goldman DA, Gerdes H, Schattner MA, Markowitz AJ, Strong VE, Brennan MF, Coit DG.

Ann Surg Oncol. 2017 Nov;24(12):3658-3666. doi: 10.1245/s10434-017-6050-9. Epub 2017 Aug 16.

PMID:
28815443
27.

Minimally Invasive Gastric Surgery.

Herrera-Almario G, Strong VE.

Adv Surg. 2017 Sep;51(1):151-164. doi: 10.1016/j.yasu.2017.03.012. Epub 2017 May 6. Review. No abstract available.

28.

Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma.

Hernandez JM, Beylergil V, Goldman DA, van Beek E, Gonen M, Tang L, Downey R, Rizk N, Shah M, Strong V, Janjigian Y, Schöder H, Coit DG.

Ann Surg. 2018 May;267(5):898-904. doi: 10.1097/SLA.0000000000002306.

29.

A RETROSPECTIVE REVIEW OF WESTERN LOWLAND GORILLA (GORILLA GORILLA GORILLA) MORTALITY IN EUROPEAN ZOOLOGIC COLLECTIONS BETWEEN 2004 AND 2014.

Strong V, Baiker K, Brennan ML, Redrobe S, Rietkerk F, Cobb M, White K.

J Zoo Wildl Med. 2017 Jun;48(2):277-286. doi: 10.1638/2016-0132R.1. Review.

PMID:
28749273
30.

Association of Hospital Costs With Complications Following Total Gastrectomy for Gastric Adenocarcinoma.

Selby LV, Gennarelli RL, Schnorr GC, Solomon SB, Schattner MA, Elkin EB, Bach PB, Strong VE.

JAMA Surg. 2017 Oct 1;152(10):953-958. doi: 10.1001/jamasurg.2017.1718.

31.

Minimally invasive surgery for gastric cancer in USA: current status and future perspectives.

Russo A, Strong VE.

Transl Gastroenterol Hepatol. 2017 Apr 30;2:38. doi: 10.21037/tgh.2017.03.14. eCollection 2017. Review.

32.

Minimally Invasive Surgical Approaches to Gastric Resection.

Gholami S, Cassidy MR, Strong VE.

Surg Clin North Am. 2017 Apr;97(2):249-264. doi: 10.1016/j.suc.2016.11.003. Epub 2017 Feb 14. Review.

PMID:
28325185
33.

Evolving application of minimally invasive cancer operations at a tertiary cancer center.

Selby LV, DeMatteo RP, Tholey RM, Jarnagin WR, Garcia-Aguilar J, Strombom PD, Allen PJ, Kingham TP, Weiser MR, Brennan MF, Strong VE.

J Surg Oncol. 2017 Mar;115(4):365-370. doi: 10.1002/jso.24526. Epub 2017 Mar 15.

34.

Minimally Invasive Surgery: The Emerging Role in Gastric Cancer.

Cassidy MR, Gholami S, Strong VE.

Surg Oncol Clin N Am. 2017 Apr;26(2):193-212. doi: 10.1016/j.soc.2016.10.001. Epub 2017 Feb 4. Review.

PMID:
28279464
35.

Electronic Rapid Fitness Assessment: A Novel Tool for Preoperative Evaluation of the Geriatric Oncology Patient.

Shahrokni A, Tin A, Downey RJ, Strong V, Mahmoudzadeh S, Boparai MK, McMillan S, Vickers A, Korc-Grodzicki B.

J Natl Compr Canc Netw. 2017 Feb;15(2):172-179.

36.

Differences in the multimodal treatment of gastric cancer: East versus west.

Russo A, Li P, Strong VE.

J Surg Oncol. 2017 Apr;115(5):603-614. doi: 10.1002/jso.24517. Epub 2017 Feb 9. Review.

PMID:
28181265
37.

Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.

Pak LM, Coit DG, Eaton AA, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Strong VE, Kingham TP.

Ann Surg Oncol. 2017 May;24(5):1174-1179. doi: 10.1245/s10434-016-5757-3. Epub 2017 Jan 5.

38.

Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma.

Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS.

Ann Surg. 2018 Jan;267(1):105-113. doi: 10.1097/SLA.0000000000002040.

39.

Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.

Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG.

Ann Surg. 2017 Dec;266(6):1006-1012. doi: 10.1097/SLA.0000000000002030.

PMID:
27759617
40.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H.

J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.

PMID:
27697982
41.

A SYSTEMATIC REVIEW OF THE LITERATURE RELATING TO CAPTIVE GREAT APE MORBIDITY AND MORTALITY.

Strong VJ, Grindlay D, Redrobe S, Cobb M, White K.

J Zoo Wildl Med. 2016 Sep;47(3):697-710. Review.

PMID:
27691977
42.

Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience.

Won E, Shah MA, Schöder H, Strong VE, Coit DG, Brennan MF, Kelsen DP, Janjigian YY, Tang LH, Capanu M, Rizk NP, Allen PJ, Bains MS, Ilson DH.

J Gastrointest Oncol. 2016 Aug;7(4):506-14. doi: 10.21037/jgo.2016.06.01.

43.

Minimally Invasive Gastric Surgery.

Herrera-Almario G, Strong VE.

Ann Surg Oncol. 2016 Nov;23(12):3792-3797. Epub 2016 Aug 3.

44.

Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.

Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, Patel SG, Downey RJ, Strong VE, Russo P.

J Surg Oncol. 2016 Sep;114(3):375-9. doi: 10.1002/jso.24327. Epub 2016 Jun 23.

45.

Decreased length of stay and earlier oral feeding associated with standardized postoperative clinical care for total gastrectomies at a cancer center.

Selby LV, Rifkin MB, Yoon SS, Ariyan CE, Strong VE.

Surgery. 2016 Sep;160(3):607-12. doi: 10.1016/j.surg.2016.04.036. Epub 2016 Jun 14.

46.

Discovery of Novel Alphacoronaviruses in European Rodents and Shrews.

Tsoleridis T, Onianwa O, Horncastle E, Dayman E, Zhu M, Danjittrong T, Wachtl M, Behnke JM, Chapman S, Strong V, Dobbs P, Ball JK, Tarlinton RE, McClure CP.

Viruses. 2016 Mar 18;8(3):84. doi: 10.3390/v8030084.

47.

Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.

Cao L, Selby LV, Hu X, Zhang Y, Janjigian YY, Tang L, Coit DG, Brennan MF, Strong VE.

J Surg Oncol. 2016 Jun;113(7):745-9. doi: 10.1002/jso.24228. Epub 2016 Apr 4.

48.

Initial report of near-infrared fluorescence imaging as an intraoperative adjunct for lymph node harvesting during robot-assisted laparoscopic gastrectomy.

Herrera-Almario G, Patane M, Sarkaria I, Strong VE.

J Surg Oncol. 2016 Jun;113(7):768-70. doi: 10.1002/jso.24226. Epub 2016 Mar 29.

49.

Patterns and Predictors of Weight Loss After Gastrectomy for Cancer.

Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, Brennan MF, Coit DG, Strong VE.

Ann Surg Oncol. 2016 May;23(5):1639-45. doi: 10.1245/s10434-015-5065-3. Epub 2016 Jan 5.

50.

Preoperative Chemoprophylaxis is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism.

Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, Scardino PT, Soff GA, Fabbri N, Sepkowitz K, Strong VE, Sarkaria IS; MSKCC VTE Task Force.

J Am Coll Surg. 2016 Feb;222(2):129-37. doi: 10.1016/j.jamcollsurg.2015.11.011. Epub 2015 Dec 15.

Supplemental Content

Loading ...
Support Center